Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Rapid Clinical and Renal Recovery after Transcatheter Tricuspid Valve Replacement.

JACC. Case reports·2026

Same author

Cell-free mitochondrial DNA and microRNA-137 for early diagnosis of preeclampsia.

Frontiers in cardiovascular medicine·2026

Same author

Exosome-Mediated Benefits of Cell Therapy in Mouse and Human Models of Duchenne Muscular Dystrophy.

Stem cell reports·2026

Same author

Radiation reprograms fibroblasts to drive prostate cancer therapy resistance.

Endocrine-related cancer·2025

Same author

Physical activity in carotid atherosclerotic patients blunts monocyte pro-inflammatory processes: a randomised controlled trial.

Atherosclerosis·2025

Same author

Corrigendum to 'Evaluating the mechanism of action behind controlled hypothermic preservation of donor hearts: A randomized pilot study' [J Heart Lung Transplant, 44 (2025) 1137-1145].

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation·2025

Search research articles

Related Experiment Video

Updated: Dec 28, 2025

White and Brown Adipose Grafts: An Approach to Correct Reproductive, Metabolic, and Renal Deficits in Black and Tan Brachyury (BTBR) Obese Mice

White and Brown Adipose Grafts: An Approach to Correct Reproductive, Metabolic, and Renal Deficits in Black and Tan Brachyury (BTBR) Obese Mice

Published on: September 9, 2025

Decrease of Cardiac Parkin Protein in Obese Mice.

Amandine Thomas¹, Stefanie Marek-Iannucci¹, Kyle C Tucker¹

¹Cedars-Sinai Medical Center, Smidt Heart Institute, Los Angeles, CA, United States.

Frontiers in Cardiovascular Medicine

|February 11, 2020

Summary

This summary is machine-generated.

Obesity reduces Parkin protein in the heart, impairing mitophagy and potentially increasing cardiovascular risk. This Parkin depletion, linked to mitochondrial dysfunction, warrants further investigation in high-fat diet models.

Keywords:

Parkin ischemia/reperfusion mitochondria mitophagy myocardium obesity

More Related Videos

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model

Published on: November 29, 2024

Body Composition and Metabolic Caging Analysis in High Fat Fed Mice

Body Composition and Metabolic Caging Analysis in High Fat Fed Mice

Published on: May 24, 2018

Related Experiment Videos

Last Updated: Dec 28, 2025

White and Brown Adipose Grafts: An Approach to Correct Reproductive, Metabolic, and Renal Deficits in Black and Tan Brachyury (BTBR) Obese Mice

White and Brown Adipose Grafts: An Approach to Correct Reproductive, Metabolic, and Renal Deficits in Black and Tan Brachyury (BTBR) Obese Mice

Published on: September 9, 2025

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model

Published on: November 29, 2024

Body Composition and Metabolic Caging Analysis in High Fat Fed Mice

Body Composition and Metabolic Caging Analysis in High Fat Fed Mice

Published on: May 24, 2018

Area of Science:

Cardiovascular Physiology
Mitochondrial Biology
Obesity Research

Background:

Mitophagy, a crucial process for heart health, relies on Parkin.
Obesity is a significant cardiovascular risk factor, with links to impaired autophagy.
The specific impact of obesity on Parkin-dependent mitophagy in the heart is not well understood.

Purpose of the Study:

To investigate the regulation of Parkin expression in mouse hearts under high-fat diet (HFD) conditions.
To assess the functional consequences of altered Parkin levels on cardiac mitochondrial health.
To explore the mechanisms behind potential changes in Parkin abundance.

Main Methods:

Mice were fed either a high-fat diet (HFD) or a low-fat diet (LFD).
Parkin protein and mRNA levels were quantified in heart tissue.
Mitochondrial function was assessed, particularly in the context of ischemia/reperfusion (I/R) injury.
Parkin degradation rates and translation were evaluated.

Main Results:

HFD significantly decreased Parkin protein levels in mouse hearts compared to LFD controls.
This reduction in Parkin was associated with impaired mitochondrial function during I/R.
Parkin downregulation was not due to decreased mRNA expression, degradation, or significantly reduced translation.

Conclusions:

High-fat diet-induced obesity leads to a reduction in cardiac Parkin protein.
Parkin depletion in obesity may contribute to cardiovascular risk by compromising mitochondrial quality control.
The precise mechanism for Parkin downregulation in HFD hearts requires further investigation.